Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15397 total
Can-Fite BioPharma heads into the week with short sellers in full retreat — a dramatic reversal from a peak that coincided almost exactly with its most important clinical readout in years. The positioning story over…
AT&T walks into its Q1 2026 earnings print tomorrow — Wednesday, May 14 — having shed 5% over the past month to $25.23, down nearly 3% on the week even after a modest bounce on Tuesday. The backdrop is one of quiet…
Inovio Pharmaceuticals has surged 24% in a week to $1.41, but its short sellers are not backing down — and the gap between those two signals makes this week's setup genuinely uncomfortable. Short interest has climbed…
PBH heads into tomorrow's Q4 earnings with a sharply contradictory setup: insiders dumped shares at the top of the week, short sellers piled in at a one-month record pace, yet options traders are leaning bullish. The…
TEF reports Q1 2026 results on May 14 with short sellers pulling back from their peak positions, borrow costs creeping higher over the month, and analysts sitting modestly above where the stock trades now. The most…
NUAG has put up one of the more eye-catching moves in the silver space this week — but insider selling through the run-up raises a question worth sitting with. The stock climbed 13% over the past five sessions to CAD…
Dyadic International closed out the week on the back foot — the stock down 6.1% on the week to $0.7228 — but the more interesting development is in the lending market, where short sellers have been cutting exposure at…
ISCG — the iShares Morningstar Small-Cap Growth ETF — enters the back half of May with short interest doubling in a month and the borrow market tightening alongside it, a notable shift in positioning against a…
OptimumBank Holdings heads into its Q1 2026 earnings tomorrow with the most bullish analyst setup it has seen in months — and the short side looking increasingly thin. The standout this week is the timing of the…
Marchex heads into the post-earnings session with a Q1 miss on both revenue and earnings, but a $10 million strategic funding deal with Archenia adds a complicating wrinkle to what would otherwise be a clean bearish…
Arrowhead Pharmaceuticals heads into mid-May with a striking divergence: the Street is growing more constructive, yet short sellers are rebuilding positions at their fastest weekly pace in over a month. Short interest…
Teekay Corporation just reported a blowout Q1 and handed shareholders a $1-per-share special dividend — yet the stock spent the week sliding, setting up an interesting tension between headline fundamentals and…
Gilat Satellite Networks just reported Q1 2026 results that encapsulate the company's central tension: a business firing on all cylinders operationally, dragged down by a revenue line that disappointed. Adjusted EPS…
Amdocs reported fiscal Q2 results just hours ago, and the setup is a familiar one for this stock: a clean beat followed by guidance that asks more patience of investors than many are willing to give. Revenue came in at…
Willamette Valley Vineyards heads into mid-May with an unusual pairing: short interest climbing at its fastest pace in months while the stock drops nearly 10% on the week — yet the borrow market itself tells a far…
U.S. Global Investors enters its May 14 earnings release with short sellers in full retreat — and the options market nudging, very gently, toward caution. The clearest story right now is the short unwind. Short…
Thermo Fisher Scientific enters its May 20 Q1 print with a notable tension: the stock trades at $459 — roughly 26% below the Street's average price target of $620 — yet analysts have spent the past month cutting those…
TISI heads into its Q1 2026 earnings release with the stock down 12.5% on the week — and a cluster of board-level purchases still sitting underwater. The week's most telling tension sits between director buying and the…
WKSP heads into the week of May 11 facing its sharpest short-selling pressure of the year — triggered by a fresh earnings miss that reinforced a now-familiar pattern of underdelivery. Short interest jumped 43% in a…
Synopsys heads into its May 27 earnings report riding a 31% one-month rally — and a fresh analyst upgrade that landed today. Citigroup raised its price target on SNPS to $600 from $580 this morning, maintaining its Buy…
